Starting with pharmaceutical communication
The business began with a messaging platform for medical and pharmaceutical companies. It subsequently added AI services for compliance work, where specialist review and strict rules make routine communication costly to manage.
Funding the next layer of automation
The company announced ¥630 million in equity and ¥100 million in debt. Its next development phase adds agent-quality evaluation and improvement capabilities, alongside hiring engineers, product managers and business-development staff.
Where the funding goes
- AI-agent platform and quality evaluation
- Product improvement and specialist hiring
Sources
- Shaperon: funding announcement
- i-nest capital: direct investor announcement and product account
- Sogyotecho: independent financing and compliance product report
- Shaperon: official messaging platform and corporate identity
- EU Official Journal: ECB announcement-day exchange rates
- Shaperon: original promotional-material review product release
- Shaperon: official email and activity monitoring product